IN8bio released FY2024 Q4 earnings on March 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -2.374 (forecast USD -2.25)

Brief Summary

On March 13, 2025 (US Eastern Time), IN8bio announced its fourth-quarter 2024 results, reporting revenue of $0 which was in line with expectations, and an earnings per share (EPS) of -$2.374, missing the consensus estimate of -$2.25.

Impact of The News

Analysis of IN8bio’s Q4 2024 Financial Results